United Kingdom· GB-APID-13799511000001107
Relistor 12mg/0.6ml solution for injection vials
A medicinal product containing methylnaltrexone bromide, registered in United Kingdom by Alliance Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Methylnaltrexone bromide
- Manufacturer
- Alliance Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 7
- gtin5010981002974
- gtin5060221470100
- gtin3830044947231
- gtin5010981002981
- gtin5060221470117
- gtin3830044947248
- gtin5397313001905
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylnaltrexone bromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRELISTORBausch Health Ireland Limited, Dublin
- BelgiumRelistor 12 mgBausch Health Ireland
- FinlandRelistorBausch Health Ireland Limited
- IrelandRelistorBausch Health Ireland Limited
- PolandRelistorBausch Health Ireland Ltd.
- SwedenRelistor 12 mg Injektionsvätska, lösning i förfylld sprutaBausch Health Ireland Ltd
- United StatesRelistorSalix Pharmaceuticals, Inc.
- SpainRELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLEBausch Health Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Relistor
- Liechtenstein · Relistor
- Norway · Relistor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3b7599c-3998-410b-816e-656311f9da76 GET /v1/drugs/d3b7599c-3998-410b-816e-656311f9da76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "13799511000001107",
"desc": "Relistor 12mg/0.6ml solution for injection vials (Alliance Pharmaceuticals Ltd)",
"form": "Solution for injection",
"vpid": "36034311000001100",
"source": "dmd",
"vtm_id": "13807711000001105",
"strength": "20 mg",
"substance": "Methylnaltrexone bromide",
"ingredient": "Methylnaltrexone bromide",
"supplier_code": "3417301000001102"
}See everything about methylnaltrexone bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.